Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMERGE: Early Metformin in Gestational Diabetes Mellitus
NCT02980276Phase 3Completed
- Sponsor
- University of Galway
- Start
- Jun 2017
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by University of Galway. Primary endpoints: Primary Composite Outcome at 16 weeks and Initiation of Insulin at 16 weeks. Started Jun 2017; status: completed.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT02980276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02980276.